ADMA Biologics, Inc. Shares Purchased by State Street Corp - MarketBeat
ADMA Stock | USD 15.83 0.56 3.42% |
About 61% of ADMA Biologics' investor base is looking to short. The analysis of the overall investor sentiment regarding ADMA Biologics suggests that many traders are alarmed. The current market sentiment, together with ADMA Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use ADMA Biologics stock news signals to limit their universe of possible portfolio assets.
ADMA |
ADMA Biologics, Inc. Shares Purchased by State Street Corp MarketBeat
Read at news.google.com
![]() |
ADMA Biologics Fundamental Analysis
We analyze ADMA Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ADMA Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ADMA Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
ADMA Biologics is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
ADMA Biologics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ADMA Biologics stock to make a market-neutral strategy. Peer analysis of ADMA Biologics could also be used in its relative valuation, which is a method of valuing ADMA Biologics by comparing valuation metrics with similar companies.
Peers
ADMA Biologics Related Equities
IBIO | Ibio | 9.95 | ||||
XFOR | X4 Pharmaceuticals | 8.11 | ||||
ATRA | Atara Biotherapeutics | 1.30 | ||||
CRBU | Caribou Biosciences | 0.86 | ||||
BCRX | BioCryst Pharmaceuticals | 0.81 | ||||
PLX | Protalix Biotherapeutics | 0.86 | ||||
MCRB | Seres Therapeutics | 1.32 | ||||
ANTX | AN2 Therapeutics | 1.75 | ||||
AKBA | Akebia Ther | 2.70 | ||||
ACLX | Arcellx | 3.38 | ||||
RCUS | Arcus Biosciences | 3.58 | ||||
INMB | INmune Bio | 3.61 | ||||
ETNB | 89bio | 3.79 | ||||
ANEB | Anebulo Pharmaceuticals | 4.31 | ||||
STOK | Stoke Therapeutics | 5.73 | ||||
TNXP | Tonix Pharmaceuticals | 6.11 | ||||
SANA | Sana Biotechnology | 6.90 | ||||
CDTX | Cidara Therapeutics | 7.43 | ||||
VXRT | Vaxart | 7.84 | ||||
FATE | Fate Therapeutics | 8.04 | ||||
MDGL | Madrigal Pharmaceuticals | 8.15 | ||||
PLRX | Pliant Therapeutics | 59.88 |
Complementary Tools for ADMA Stock analysis
When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |